Results

Moleculin Biotech Inc.

12/01/2021 | Press release | Distributed by Public on 12/01/2021 07:37

Moleculin Receives FDA Allowance to Begin a Phase 1 Study of WP1122 for the Treatment of Glioblastoma Multiforme